RxRxBriefing
Pharma

AbbVie ABBV

AbbVie Inc.Pharmaceutical PreparationsDE

Pipeline — registered trials by phase

A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Participants
— · Masseter Muscle Prominence · Completed · est. 2025-07-31
A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
— · Ulcerative Colitis (UC) · Completed · est. 2021-12-13
An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
— · Uterine Fibroids, Heavy Menstrual Bleeding · Completed · est. 2018-05-07
Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis
— · Ulcerative Colitis (UC) · Completed · est. 2019-09-05
A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus
— · Respiratory Syncytial Virus (RSV) · Completed · est. 2017-07-13
A Study to Evaluate Leuprolide Acetate 45 mg 6-Month Formulation in Children With Central Precocious Puberty (CPP)
— · Central Precocious Puberty (CPP) · Completed · est. 2021-05-06
Efficacy and Safety of Adalimumab in Patients With Active Uveitis
— · Uveitis · Completed · est. 2014-07
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection
— · Chronic Hepatitis C, Hepatitis C Virus, HCV · Completed · est. 2017-01
A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants in China With Fine Lines Around the Mouth
— · Perioral Lines · Completed · est. 2024-09-03
Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease
— · Crohn's Disease · Completed · est. 2016-11-03
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
— · Acute Myeloid Leukemia · Recruiting · est. 2032-06
A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer in Adult Participants
— · Non-Small Cell Lung Cancer · Not Yet Recruiting · est. 2029-12
A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence
— · Platysma Prominence · Completed · est. 2023-06-14
Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa
— · Hidradenitis Suppurativa (HS) · Completed · est. 2014-04
The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone
— · Major Depressive Disorder · Completed · est. 2021-09-06
Study of Adalimumab in Patients With Axial Spondyloarthritis
— · Axial Spondyloarthritis · Completed · est. 2011-02
Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
— · Moderate to Severe Plaque Psoriasis · Completed · est. 2009-04
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
— · Migraine · Recruiting · est. 2027-05
Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.
— · Ulcerative Colitis · Active Not Recruiting · est. 2028-08
A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence
— · Masseter Muscle Prominence · Completed · est. 2025-11-25
Open Label Continuation Study in Moderate to Severe Psoriasis
— · Moderate to Severe Plaque Psoriasis · Completed · est. 2011-10
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
— · Crohn's Disease · Recruiting · est. 2029-04
A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants Previously Treated, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
— · Non-Squamous Non-Small Cell Lung Cancer · Not Yet Recruiting · est. 2030-03
A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study
— · Hepatitis C · Completed · est. 2016-10
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)
— · Hepatocellular Carcinoma · Active Not Recruiting · est. 2027-01
Source: ClinicalTrials.gov (trials where AbbVie is lead sponsor; 86 active or completed) and Drugs@FDA (38 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.

SEC filings — insider trading forms excluded

Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.